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Abstract
Here we examine the functions of the Myc cofactor and histone acetyltransferase, GCN5/KAT2A, in neural stem and
precursor cells (NSC) using a conditional knockout approach driven by nestin-cre. Mice with GCN5-deficient NSC exhibit a
25% reduction in brain mass with a microcephaly phenotype similar to that observed in nestin-cre driven knockouts of c- or
N-myc. In addition, the loss of GCN5 inhibits precursor cell proliferation and reduces their populations in vivo, as does loss of
N-myc. Gene expression analysis indicates that about one-sixth of genes whose expression is affected by loss of GCN5 are
also affected in the same manner by loss of N-myc. These findings strongly support the notion that GCN5 protein is a key N-
Myc transcriptional cofactor in NSC, but are also consistent with recruitment of GCN5 by other transcription factors and the
use by N-Myc of other histone acetyltransferases. Putative N-Myc/GCN5 coregulated transcriptional pathways include cell
metabolism, cell cycle, chromatin, and neuron projection morphogenesis genes. GCN5 is also required for maintenance of
histone acetylation both at its putative specific target genes and at Myc targets. Thus, we have defined an important role for
GCN5 in NSC and provided evidence that GCN5 is an important Myc transcriptional cofactor in vivo.
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Introduction
GCN5/KAT2A was one of the first histone acetyltransferase
(HAT) linked to transcriptional activation [1] and regulates a
chromatin program of histone acetylation that is required for
normal embryogenesis. GCN5 null embryos exhibit elevated
apoptosis in the mesodermal lineage [2]. More recently, mice
with a conditional GCN5 allele were created as well as mice with a
knock-in of a catalytically dead GCN5 (GCN5
HAT/HAT), which
exhibit a neuronal phenotype with no apoptosis [3]. GCN5 is also
essential for normal embryonic stem cell pluripotency [4]. More
recently loss of GCN5 has been shown to accelerate cerebellar
degeneration in a mouse model of neurodegeneration [5]. Despite
these studies and the fact that GCN5 is one of the most thoroughly
studied HATs as part of the SAGA complex in yeast [1], very little
is known about its function in normal development. Myc is the
most well-studied DNA binding factor that recruits GCN5 to
activate transcription, but E2F [6] and other factors such as p53
recruit it as well [7].
GCN5 also has a more global role in histone acetylation of
unknown function [8] that could be involved in Myc’s global
regulation of histone acetylation [9,10]. Furthermore, the impor-
tance of GCN5 for Myc function in vivo, such as during normal
brain development, remains unknown as all studies of GCN5
function as a Myc cofactor have been conducted in immortalized
cell lines. While GCN5 substrates can include K9, K14 and K18 of
histone H3 as well as all 4 amino-terminal K residues of histone
H4 [11], the identity of endogenous substrates also remains an
open question. We have previously found that the global
chromatin function for Myc in maintaining AcK9 and acetylation
of histone H4 in NSC appears to involve a role for GCN5 as a Myc
target gene [9]. However, the potential role of GCN5 protein as a
cofactor for Myc in NSC in vivo remains unexamined in any
developmental system.
The myc family of proto-oncogenes encodes chromatin regula-
tory proteins belonging to the basic-helix-loop-helix zipper
(bHLHZ) class of transcription factors (reviewed in [12]). Related
bHLHZ proteins called Mad/Mxd proteins antagonize Myc
transcriptional functions and its influence on cell biology [13].
Both Myc and Mxd proteins bind DNA as dimers with a small,
related bHLHZ protein, Max. Evidence for the antagonism
between Myc and Mxd proteins on chromatin comes from the
discovery that once bound to chromatin, Myc and Mxd proteins
recruit opposite types of chromatin modifying enzymes. Beyond
GCN5 [6,14], Myc proteins recruit other HATs as well including
TIP60/KAT5 [15] and p300/KAT3B, while Mxd proteins recruit
histone deacetylases (HDACs) via the mSin3 corepressor [16,17].
Chromatin immunoprecipitation assays (ChIP) have shown that
Myc binding correlates strongly with histone acetylation, including
acetylation of lysine 9 (AcK9) of histone H3 in the vicinity of
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same residues [19]. Myc has been linked to histone lysine
methylation as well via JARID demethylases [20]. This evidence
along with the HAT and HDAC studies, points toward a central
role for Myc and Mxd proteins in regulating the relative level of
histone modifications via HDACs and HATs such as GCN5.
While excess myc is strongly associated with cancer, myc has also
been linked with normal regulation of a variety of stem cells
including NSC. It also plays an important role in the production of
induced pluripotent stem cells (reviewed in [21]). Both c- and N-
myc are constitutively required for embryogenesis [22,23] as well as
for embryonic stem cell function [24,25,26]. N-Myc plays a critical
role in normal murine brain growth by controlling NSC function
via regulation of global chromatin and specific target genes
[9,27,28]. Nestin-Cre driven N-myc conditional KO in NSC
severely disrupts murine brain growth, while c-myc disruption in
NSC modestly impairs growth [29,30]. The particular Nestin-Cre
transgene used in these studies becomes weakly activated around
E9.5 with apparent peak Cre expression in NSC in vivo around day
E12.5 [31] and the transgene remains active in neurospheres as
well [29]. A similar role for N-myc in human NSC is inferred from
studies demonstrating that the human microcephaly syndrome,
Feingold Syndrome, is caused by mutations in MYCN [32].
Normally, cortical precursor cells are located in two prolifer-
ative zones: the ventricular zone (VZ) and the subventricular zone
(SVZ). VZ and SVZ precursor cells can be identified based on
expression of the intermediate filaments nestin and vimentin
[33,34]. In previous studies, disruption of N- and/or c-myc affected
precursors in both zones and attenuated cortical expansion [28].
Targeted gene disruption of either c-myc or N-myc or both in
hematopoietic stem cells also alters their survival and self-renewal
[35,36]. A murine double KO (DKO) of both c-myc and N-myc
using nestin-cre produced an extremely severe, often lethal
phenotype including a near complete disruption of postnatal
cerebellar development [27,28].
The extent to which the GCN5 gene or GCN5 protein are
necessary for Myc’s chromatin, transcriptional, and biological
functions in vivo during development is unknown. More specifical-
ly, the potential roles of Myc cofactors such as GCN5 in N-Myc
function in NSC and brain growth remain important open
questions. To address these issues, here we have used targeted
gene disruption to knockout GCN5 specifically in NSC both in vivo
and in vitro. We found that GCN5 is required in NSC for normal
brain growth, producing a microcephaly phenotype similar to the
nestin-cre driven myc KOs. In addition, loss of GCN5 decreases
stem cell proliferation in the cerebral cortex. KO of GCN5 in NSC
produces gene expression changes that strongly overlap with those
observed in N-myc KO NSC. Together these findings provide the
first evidence that GCN5 and a Myc protein family member
regulate significantly overlapping transcriptional programs in vivo.
Results
Production of Mice with Neural Stem and Precursor Cell
(NSC) Specific Targeted Disruption of GCN5
To generate a GCN5 KO specifically in NSC we took advantage
of the well-characterized nestin-cre transgene, which we have
previously used to make c- and N-myc NSC-specific KO mice
[29,30,37]. We bred nestin-cre mice and mice with GCN5 floxed
alleles in which the vast majority of the GCN5 coding region is
flanked by LoxP sites [38]. We used a breeding strategy where we
crossed GCN5 flox/flox mice with GCN5 flox/flox nestin-cre+ mice
(Fig. 1A), producing 100% pups that are GCN5 floxed. According
to predictions from Mendelian genetics, in the absence of a lethal
KO phenotype these pups should be 50% nestin-cre+ and 50%
nestin-cre-. These crosses produced modest, but not statistically
significant (p,0.08) evidence of lethality, as KO (nestin-cre+) mice
were 15% underrepresented (Fig. 1A). Nonetheless, the surviving
mice outwardly appear phenotypically normal with only a minor
decrease in head size (not shown) that was suggestive of the
microcephaly we have previously observed with nestin-cre
mediated KO of c- or N-myc.
Mice with GCN5 Deficient NSC Exhibit Impaired Brain
Growth and Microcephaly
To examine the overall effects of loss of GCN5 in NSC on brain
growth, we conducted timed matings, isolated embryos and
microdissected E14.5 and E17.5 control flox/flox and GCN5 KO
(flox/flox nestin-cre+) brains (Fig. 1B–C). The size of the cerebral
cortex and also the size of the cerebellum were proportionally
reduced in the KOs. At E14.5 there was a visibly evident decrease
in null brain size, particularly along the rostro-caudal axis (Fig. 1B).
At E17.5, the GCN5 KO brains were further reduced in relative
size compared to littermate controls (Fig. 1C). Importantly, the
size of the null cerebral cortex was decreased both in the rostro-
caudal and medio-lateral axes at E17.5. We quantitated the
reduction in size in different stages of the developing GCN5 KO
cortex. At E14.5, the null cortex was reduced 17% 63 in the
rostro-caudal axis, but it was not reduced in the medio-lateral axis.
At E17.5, there was a reduction of 29% 64 in rostro-caudal and of
25% 64 in the medio-lateral axes. By adulthood the null brain
was significantly reduced in mass (null mass was reduced to 74% of
WT; Fig. 1D) and in size (Fig. 1E). In the GCN5 null adult, the
reduction in size was of 16% 62 in rostro-caudal and 10% 63i n
the medio-lateral axes.
Disruption of GCN5 Results in Decrease in Precursor Cell
Proliferation in the Developing Cerebral Cortex
The 26% reduction in brain mass in the adult GCN5 NSC KO
mice indicated that the loss of GCN5 in NSC was inhibiting normal
brain growth. Two potential causes of impaired brain growth are
reduced cell cycling and increased apoptosis. To examine these
possibilities we stained sections from the developing GCN5 NSC
KO mice with an antibody against phosphorylated vimentin (4A4),
a marker for dividing precursor cells (Fig. 2). The GCN5 KO
ventricular zone (VZ) exhibited a marked decrease in the number
of 4A4+ dividing precursor cells in all the developmental stages
examined. We quantified the number of VZ 4A4+ cells present in
a radial unit of dorsal cortex 100 mm wide spanning from the
surface of the lateral ventricle to the pial surface. The number of
4A4+ cells in the null E12.5 VZ decreased by more than half
(E12.5 control=11.561.5 cells; E12.5 KO=5.061.3, p=0.01);
the number of 4A4+ cells in the E14.5 VZ decreased almost by
half, (E14.5 control=660.9 cells, E14.5 KO=3.560.6, p=0.06);
and the number of 4A4+ cells in the E17.5 VZ decreased by one
third (E17.5 control 3.961.1, E17.5 KO=2.260.6, p=0.06;
Fig. 2 A–G).
Effects of the E17. 5 GCN5 KO were more pronounced
specifically in the subventricular zone (SVZ) compared to the VZ.
The number of 4A4+ mitotic cells in the SVZ was quantified in a
radial unit of dorsal cortex 100 mm wide spanning from the surface
of the lateral ventricle to the pial surface. We found that the
number of SVZ mitoses in the E17.5 cortex was decreased three-
fold in the GCN5 KO (E17 control=2.260.8, E17 KO=0.760.4,
p=0.03, Fig. 2E–F, H). Together these data show that the
cerebral cortex of the GCN5 KO mice is reduced in size and that
the number of dividing precursor cells per radial unit is decreased,
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precursor cells in the GCN5 null developing cerebral cortex. Since
we did not observe a change in apoptosis by TUNEL staining in
the GCN5 KO (not shown), consistent with previous GCN5 loss of
function studies [3], our findings suggest that one major
mechanism behind the decreased brain mass and size is reduced
precursor cell proliferation.
Separate Disruption of GCN5 and of N-myc in NSC Leads
to Strongly Overlapping Gene Expression Changes
To examine gene expression changes in the GCN5 KOs, we
established E12.5 neurosphere cultures from control (flox/flox)
and GCN5 KO (flox/flox nestin-cre) embryos. We isolated RNA
from these neural stem and precursor cells and measured GCN5,
Cre, and PPIA (loading control) levels by RT-PCR. As expected,
we found that the GCN5 KO neurospheres exhibited undetectable
GCN5 levels and N-myc null (N-myc floxed nestin-cre+) neuro-
spheres did not express detectable N-myc (Fig. 3A).
Having validated the effectiveness of the KOs in neurospheres,
the control and GCN5 KO RNA samples were used for expression
microarray studies, as were RNAs from control and N-myc KO
neurospheres in parallel. To our knowledge, this was the first
reported expression microarray study of a myc gene and a Myc
protein cofactor gene, in this case GCN5, in parallel. The loss of N-
myc resulted in the downregulation of approximately 4000 genes
by 1.5 fold or more, while the loss of GCN5 downregulated about
2700 genes (Fig. 3B). Strikingly, of the 2700 genes downregulated
in the GCN5 KO, 453 (17%) were also downregulated in the N-myc
KO neurospheres (Table S1). This overlap in downregulated
genes had a p value ,10
228. There was also substantial (15%)
overlap between upregulated genes in the GCN5 and N-myc KO
neurospheres, with a p value ,10
232 (Table S2). Thus, a highly
statistically significant fraction of genes was influenced by both N-
Myc and GCN5 in the same manner in NSC in independent
experiments.
Ontological Analyses of Target Genes Indicate Roles for
N-Myc and GCN5 in Regulating Stem and Precursor Cell
Fate
Using DAVID gene ontological (GO) analysis (http://david.
abcc.ncifcrf.gov), we analyzed the ontology of genes there were
either down- or upregulated in N-myc and GCN5 KO neurospheres
(Tables 1–2). When analyzing the lists of actual genes with altered
expression we focused further on genes with 2-fold or greater up or
downregulation in both KOs (Tables 1–2). Of the downregulated
genes that are putative targets of coactivation by N-Myc and
GCN5, many exhibited very striking decreases in expression in
both KOs (Table 1). A group with 10-fold or greater changes in
both N-myc and GCN5 KOs included the following: CLDN11, LTK,
H2-AB1, DSCR1L1 (RCAN2), SULF1, DBX2, GRIFIN, ITIH3,
MYOM3, and EMP1. CLDN11 encodes OSP, Oligodendrocyte
Specific Protein, which is specifically expressed in oligodendro-
cytes. The pronounced decrease in CLDN11/OSP expression in
both KOs suggests that N-Myc and GCN5 are required for
maintaining normal oligodendrocyte differentiation-associated
gene expression. Many known Myc target genes were downreg-
ulated in the GCN5 KO, including for example EMP1/TMP [39].
The genes most strongly upregulated by loss of either GCN5 or N-
myc included transcription factors such as MITF, which is
important in retinal development and melanoma [40]. EPHA5,
ephrin A5, was also strongly upregulated in both KOs and is
important in axon guidance [40]. Importantly, the NSC marker
gene, Prom1 (CD133), was separately downregulated in both the
N-myc and GCN5 KOs. We chose six genes that exhibited
downregulation in both KOs to analyze by RT-PCR, finding
that the trends indicated in the array data were mostly confirmed,
Figure 1. Mice with GCN5 KO NSC have impaired brain growth. (A) Homozygously GCN5 floxed mice were crossed with homozygously floxed
nestin-cre+ mice, producing knockout mice (homozygous nestin-cre+) at a slightly less than predicted ratio. The dashed lines represent the number
predicted based on Mendelian ratios. (B–C) Brains at E14.5 and E17.5 were isolated with evidence of impaired brain growth in the GCN5 KOs at both
stages. (D–E) Adult GCN5 KO brains were smaller in mass and size. Scale bars are 2 mm in each image. Error bars are standard deviations.
doi:10.1371/journal.pone.0039456.g001
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(Fig. 3C). In addition, EMP1 was not clearly downregulated in the
N-myc KO neurospheres.
Genes associated with neuronal differentiation and synapse
formation were upregulated in both the N-myc and GCN5 KOs,
while genes involved in post-synaptic cell membrane function were
up in the N-myc KO alone (Table 1). A set of genes known as
neuron projection morphogenesis genes were upregulated in both
the GCN5 and N-myc KOs: DSCAM, POU4F3, SLITRK1, APBB1,
ANK4, EFNA5, GBX2, HOXA2, NGFR, and RELN. These genes
have a role in initiation, extension, and connection of axons and
dendrites. For example, DSCAM mutant mice have defects in
arborization of processes and spacing of cell bodies [41]. SLITRK1
is expressed in mature neurons and its overexpression induces
growth of unipolar neurites but not multipolar neurites [42]. Gbx2,
expressed in the dorsal thalamus, controls growth and the capacity
of neurites to reach their appropriate target [43]. In addition,
Bcl11a is upregulated more than a 1000-fold in N-myc KO
neurospheres and 4-fold in GCN5 KO neurospheres. Bcl11a is a
zinc-finger transcription repressor required to control axon
branching and dendrite outgrowth [44]. More broadly, it is
notable that independent knockout of N-myc or GCN5 also led to
downregulation of a host of the same transcription factor-encoding
genes in addition to Bcl11a (Table 3).
Evidence that N-myc and GCN5 also Regulate Gene
Expression in NSC Independently of Each Other
Both N-myc and GCN5 have strong associations with ontological
functional groups that are not shared between the two, suggesting
some independent transcriptional functions (Tables 1–2). Interest-
ingly, given our previous studies suggesting chromatin condensa-
tion in N-myc null NSC and a global role for Myc proteins in
positive regulation of euchromatin, one class of gene upregulated
in the N-myc KO (but not GCN5 KO) was the ‘‘Condensed
Chromatin’’ class. This might suggest that N-myc indirect
regulation of chromatin through transcriptional control of effectors
in NSC is at least partially GCN5-independent. N-myc alone also
was positively linked to expression of genes involved in tight
junctions, mitochondrial function, and fatty acid metabolism.
Figure 2. Loss of GCN5 reduces NSC proliferation and increases differentiation along the oligodendrocyte lineage. Proliferating 4A4+
cells in the ventricular zone (VZ) of E12.5 control (A), E12.5 GCN5 KO (B), E14.5 control (C), and E14.5 GCN5 KO (D). Notice than fewer cells are 4A4+ in
the VZ of the KOs than in the control mice. Proliferating 4A4+ cells in the VZ and subventricular zone (SVZ) of E17.5 control and GCN5 KO (E,F). There
are fewer 4A4+ cells in the SVZ of the KOs than in the control mice. Some of the dividing 4A4+ cells at the VZ are indicated with an arrow, and the
dividing 4A4+ cells at the SVZ are indicated with an arrowhead. Scale bar: A-F: 10 mm. Error bars are standard deviations.
doi:10.1371/journal.pone.0039456.g002
N-Myc and GCN5 Share Transcriptional Functions
PLoS ONE | www.plosone.org 4 June 2012 | Volume 7 | Issue 6 | e39456GCN5 was uniquely linked to positive expression of cytochrome
P450, Cadherin, and DNA repair genes.
GCN5 is Required for Maintenance of Histone Acetylation
at N-Myc Target Genes and for more Widespread Histone
Acetylation in NSC
To explore the potential role of N-Myc recruitment of GCN5 in
mediating histone acetylation at N-Myc target genes, we
conducted ChIP assays. ChIP assays for murine GCN5 using
four commercially available antibodies did not in any case produce
a detectable band (not shown) at any of the N-Myc or GCN5
target genes. However, focusing on a key GCN5 target for
acetylation (lysine 9 of histone H3; AcK9), we conducted ChIP
assays for AcK9 as well as RNA Pol II at N-Myc target genes. We
found that GCN5 KO NSC had greatly decreased levels of both
histone acetylation and RNA Pol II (Fig. 4A) at the GCN5 and ccd2
(cyclin D2) gene promoters. We found the same pattern using a
second independent set of control and GCN5 KO NSC (Fig. 4B),
finding decreased AcK9 at the promoters of Apex1, GCN5, and Pol
II. GCN5 appears to be required to maintain acetylation of both
histone H3 (AcK9) and histone H4 as both AcK9 and AcH4 (pan-
acetylated histone H4 antibody) were reduced at the Lcn2 gene
promoter in GCN5 KOs (Fig. 4C). When we looked at histone
acetylation levels more globally by immunostaining of NSC, we
found no clear decrease in global AcK9 (not shown) in GCN5 KOs,
but a striking decrease in acetylation of histone H4 (Fig. 4D).
These findings suggest GCN5 is key for the maintenance of AcK9
at specific target gene promoters and more widely for overall
acetylated histone H4 levels.
Discussion
This study is the first to measure in parallel the potential
cooperative functions of a transcription factor (N-Myc in this case)
and its recruited HAT cofactor (GCN5) using mouse genetics to
perform parallel target gene disruption. We found that the HAT
GCN5 is required in NSC for brain growth and produces a
phenotype with both some similarities and differences from the N-
myc KO phenotype using the same nestin-cre. Parallel expression
microarray studies indicated that approximately 1/6 of genes
regulated by GCN5 are also regulated by N-Myc. The simplest
model to explain this overlap is that N-Myc is recruiting GCN5 to
these genes to control their expression, a model that fits for genes
that are downregulated by KO of N-myc or GCN5. However,
interestingly there is also strong overlap between genes upregu-
lated in both N-myc and GCN5 KO NSC, representing putative
targets of N-Myc and GCN5 repression. The striking overlap in
genes activated by either N-Myc or GCN5 loss-of-function
Figure 3. GCN5 and N-Myc regulate overlapping program of
gene expression in NSC. (A) RNAs were isolated from control and
GCN5 KO neurosphere lines as well as from control and N-myc KO
neurosphere lines. The KO in each case was verified by RT-PCR including
PPIA for the loading control. (B) Expression microarrays were conducted
on the RNAs and analyzed for overlap between genes altered in the
GCN5 and N-myc KOs. Overlap is indicated in the Venn diagrams along
with p values. (C) Expression changes of select genes as measured by
array were validated by RT-PCR.
doi:10.1371/journal.pone.0039456.g003
Table 1. Ontological Gene Clusters Upregulated in KOs (p values shown).
Category N-myc KO GCN5 KO SHARED GENES
Phosphatase 4.0610
223 2.8610
212 DUSP4, PTPRK, PTPRO, PTPRD
Post-Synaptic Membrane 2.2610
28
Ras signaling 1.0610
28
Neuron differentiation 1.7610
27 3.2610
25 BCL11B, ANK3, SLITRK1
Peptidase (ADAM) 1.6610
26 7.9610
211 ADAM12, ADAMTS5, ADAMTS1, ADAM23
Synapse formation 1.0610
26 1.0610
26 SYT1, SV2A, SYT9
Condensed Chromatin 1.3610
25
doi:10.1371/journal.pone.0039456.t001
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and GCN5 normally by some mechanism) suggests, not surpris-
ingly, that at least some indirect effects on gene expression occur
since histone acetylation driven by GCN5 is proposed to strictly
activate genes. One possible model for derepression of genes in
both knockouts is that N-Myc and GCN5 work together to
activate expression of genes encoding repressor proteins that in
turn suppress expression of genes in specific functional pathways.
Of downregulated genes, N-Myc and GCN5 null NSC shared
many ontological clusters including, most prominently, those
related to signaling including Ras and Wnt. If N-Myc and GCN5
function together, in part, to coordinately regulate Ras and Wnt
signaling, then the disruptions in these pathways in the KOs may,
at least in part, explain the changes in cell fate observed in both
KOs. Importantly, while both N-myc and GCN5 KOs exhibited a
downregulated Wnt cluster, the genes within the clusters were
entirely different as no specific Wnt pathway genes were
downregulated in both KOs. This suggests that N-Myc and
GCN5 have distinct effects on Wnt signaling. In addition, the Ras
clusters downregulated in each KO only partially overlapped,
indicating that GCN5 and N-Myc regulate both distinct and
shared aspects of NSC signaling, likely explaining the differential
effects of their loss on cell fate. Together these findings suggest that
N-Myc and GCN5 may in part influence development via
complex regulation of signaling pathways.
The strong downregulation of ubiquitin pathway genes (e.g.
FBXO32 and FBXO36) in both KOs supports the model in which
N-Myc and GCN5 together are positive regulators of the activity
of the proteome, and suggests in their absence there are not only
transcriptional changes but also widespread alterations in protein
levels due to enhanced stability. These posttranscriptional events
are also likely mechanisms underlying the brain growth and fate
phenotypes observed in the KOs. N-Myc and GCN5 also both
strongly inhibit phosphatase and peptidase gene expression (the
expression of genes in these classes are upregulated in both KOs),
while interestingly N-myc and GCN5 are also required for
maintained expression of peptidase inhibitors. These data strongly
suggest N-myc and GCN5 have a role in delimiting peptidase
activity in NSC.
While the overlap between genes transcriptionally regulated by
GCN5 and N-Myc was highly significant statistically, the presence
of a majority of gene expression changes that were not shared also
suggests a significant divergence of many functions. More
specifically, it argues that N-Myc is frequently recruiting other
HATs, such as TIP60 and p300, to regulate NSC functions, and
that GCN5 is often recruited by transcription factors besides N-
Myc. The dramatic cerebellar phenotype in the nestin-cre driven
N-myc KO mice coupled with the absence of any disproportionate
cerebellar phenotype in the nestin-cre driven GCN5 KO mice,
indicates that N-Myc protein likely functions to direct cerebellar
development independently of GCN5 through another HAT.
Thus, an intriguing question is whether GCN5 has any role in the
genesis of the cerebellar tumor medulloblastoma that is frequently
associated with Myc family gene amplification. Future studies
knocking out additional Myc cofactors such as TIP60, p300, and
JARID factors in NSC employing the same nestin-cre are likely to
shed further light on Myc function in brain development and brain
Table 2. Ontological Gene Clusters Downregulated in KOs (p values shown).
Category N-myc KO GCN5 KO SHARED GENES
Ras signaling 9.2610
217 3.8610
213 Diras1, RHOU, RAB3D
Fatty acid metabolism 1.6610
216
Mitochondrial inner membrane 1.1610
216
Tight junctions 1.0610
214
Ubiquitin conjugation 1.5610
210 1.7610
217 FBXO32, FBXO36
Wnt signaling 1.2610
29 3.6610
25
Peptidase Inhibitor 1.6610
27 1.0610
211 ITIH3, many serpins
EMP family 1.0610
26
Negative regulation of cell differentiation 1.0610
26
Notch signaling 2.9610
25
Negative regulation of neuron differentiation 1.0610
25
Cytochrome P450 1.0610
213
Cadherin 2.2610
222
DNA repair 3.2610
211
Neuron differentiation 1.0610
27
doi:10.1371/journal.pone.0039456.t002
Table 3. Transcription Factors Downregulated in Kos.
Fold-changes
N-myc KO GCN5 KO
BCL11a 1739.0 4.0
DBX2 50.0 26.4
HDAC11 23.4 2.8
HES5 10.5 4.0
JUNB 8.2 4.4
SHOX2 5.1 20.9
GATA2 4.4 2.1
PDLIM1 2.9 3.2
OTX1 2.6 2.3
TGIF 2.4 3.6
doi:10.1371/journal.pone.0039456.t003
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GCN5 using nestin-cre may provide mechanistic insight into not
only their function, but also that of GCN5.
The enhanced neuronal differentiation phenotype in the N-myc
KO in vivo and in NSC is reflected in the changes in the gene
expression array studies, including upregulation of neural differ-
entiation genes by ontological analysis and downregulation of a
cluster of differentiation inhibitory genes. GCN5 KO also results in
upregulation of some neural differentiation genes, including some
that are shared with N-Myc such as BCL11A, BCL11B, ANK3,
and SLITRK1. Interestingly, GCN5 KO leads to downregulation
of neuronal differentiation genes, the gene expression changes that
are perhaps dominant in the GCN5 KO given the impaired
neuronal differentiation observed in vivo in the GCN5 KO.
Our studies of the parallel loss-of-function between N-Myc and
GCN5, supporting the model of their cooperative function to
regulate gene transcription and NSC biology, suggest that other
parallel transcription factor/histone modifying enzyme cofactor
knockout studies incorporating both phenotypic analysis and gene
expression analysis may prove fruitful. The findings that N-Myc
and GCN5 appear to work together to maintain a progenitor-like
state of inhibited differentiation, high cellular metabolism, and
rapid proliferation also support a model in which GCN5 may
mediate aspects of nervous system tumor formation by excess N-
Myc when such a progenitor-like state appears to be ‘‘locked in.’’
Further studies will provide additional insight into the functions of
N-Myc and GCN5 in NSC and tumorigenesis.
Methods
Immunohistochemistry and Measurements
All E12.5 embryos were immersion-fixed overnight in fresh 4%
paraformaldehyde (PFA) in Phosphate Buffered Saline (0.1 M
PBS), paraffin embedded and 12 mm sagittal slices were cut in a
microtome. Pregnant females were anesthetized with 150 mg/kg
ketamine and 16 mg/kg xylazine, then E14.5 and E17.5 embryos
were removed individually and perfused with PFA. Brains were
removed and fixed overnight in fresh PFA, then cryopreserved
with 30% sucrose and 12 mm coronal slices were cut in a cryostat.
For immunostaining, E12.5 embryo sections were deparaffinized
then rehydrated and 30 mM sodium citrate treated for 10 min at
95uC, while E14.5 and E17.5 frozen brain sections were post fixed
at 220uC acetone for 10 min followed by three 5-minute PBS
washes. All sections were blocked in 10% normal goat serum in
PBS for 1 hr at room temperature then incubated in primary
antibody overnight at 4uC. Antibodies used include anti-
phosphorylated vimentin (Mouse anti-4A4,1:1000, MBL, D076-
3, Toronto, Canada), Goat anti-Olig2 (1:250, R&D Systems,
AF2418, MN, USA), Mouse anti-NeuN (1:1000, Chemicon, MAB
377, MA, USA), Rabbit anti-S100 (1:500, Abcam, ab52642,
Cambridge, UK). The next day sections were washed in PBS three
Figure 4. GCN5 maintains histone acetylation at specific target genes and in a widespread manner in NSC. (A–C) ChIP assays were
conducted on control and GCN5 KO NSC lines at both N-Myc (A–B) and GCN5 target genes (C). GCN5 binding itself was undetectable at any target. ‘‘a’’
and ‘‘b’’ represent biological replicate sets of neurospheres isolated from littermate embryos. (D) Control and GCN5 KO NSC were immunostained for
pan-Ac-H4 (Red) and DAPI (Blue). Scale Bars are 100 mM.
doi:10.1371/journal.pone.0039456.g004
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for 2 hrs at room temperature. Donkey anti-Rabbit, donkey anti-
Goat, and donkey anti-Mouse were used (1:200, Jackson
Immunoresearch Laboratories, PA, USA). Sections were washed
again in PBS three times for 10 minutes each, and then mounted
in Vectashield mounting medium with DAPI (VECTOR H-1200,
CA, USA). TUNEL staining was performed using the DeadEnd
Fluorometric TUNEL System Kit (Promega G3250, WI, USA) as
directed.
For quantitation of proliferation by 4A4 staining we used n=3
for each group and the standard deviations are from different
embryos. Changes in the sizes of brains were quantified by using
microscopy and image analysis to measure sagittal (length) and
coronal (width) slices.
ChIP Assays
Chromatin samples were prepared as previously described [45].
Neurospheres were crosslinked as monolayers. Antibodies used for
ChIPs include the following: N-Myc (2 mg Abcam 16898,
Cambridge, UK), AcK9 (2.5 mg 06–942 Upstate, MA, USA),
and AcH4 (Upstate 06–866, MA, USA). 2 mg Rabbit IgG was
used as a background control. Immunoprecipitated chromatin
fragments were amplified by PCR using primers specific for each
promoter region. If inputs between GCN5 control and KOs were
substantially different, samples were re-run. Murine GCN5 ChIPs
were unsuccessfully tried with the following antibodies: Abcam
18381, Cell Signaling 3305, Santa Cruz 20698, and Santa Cruz
6303. In those experiments IPs were conducted with antibodies for
other factors including N-Myc, Pol II, and AcK9H3, which all
worked indicating that the ChIP assays themselves worked, but
that murine GCN5 is not ChIP’able using these antibodies.
ChIP primers.
mCcd2 prom 1: GGC TTA AGA AGC ACC CCT TT.
mCcd2 prom 2: CTC TAA CTT CGG AGG CTT GC.
mGCN5 L2 1: AGC ATC CAC AAA TCC TCC AG.
mGCN5 L2 2: TAG TCT TCC TTT GCC GCT TC.
mApex1 1: ACG AAC AAC CCA GAA CCA AG.
mApex1 2: CTA AGC CAG AGA CCC TCA CG.
mPolII 82s: GAC GGG TTC TGA GCA CTT AG.
mPolII 151a: CAA CAT CAG CAT CAC TGA CC.
Lcn2 1: GTG CTT AGC TCC TAT ATG CAG C.
Lcn2 2: CTG AGC AGG GCA TAG ATC CTT.
Microarray and RT-PCR
AGE Total RNA was isolated from control and GCN5 KO
neurospheres (the same set of samples as shown in Fig. 3A) using
RNeasy Mini Kit (Qiagen 74134, CA, USA) with DNaseI
digestion (Invitrogen 18068–015, CA, USA) performed post
RNA extraction after approximately 1 month in culture. Quality
of RNA was checked and cRNA was produced by UC Davis Gene
Expression Analysis facility for hybridization to Sentrix Mouse
Ref-8 Expression microarray. RT-PCR was performed on total
RNA from the same batch used for array. Four GCN5 control
(CON) and two GCN5 knockout (KO) biological replicates were
used for the array data analysis, and the genes indicated in Fig. 3B
as up- or downregulated were restricted to those showing
consistent changes in replicates.
Neurosphere Assays
Neurospheres were isolated, cultured, and differentiated as
previously described [29].
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